XRAY vs. MMSI, HAE, ICUI, QDEL, NEOG, STAA, CERS, OSUR, UTMD, and ANIK
Should you be buying DENTSPLY SIRONA stock or one of its competitors? The main competitors of DENTSPLY SIRONA include Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), and Anika Therapeutics (ANIK). These companies are all part of the "health care supplies" industry.
DENTSPLY SIRONA vs.
Merit Medical Systems (NASDAQ:MMSI) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends.
Merit Medical Systems has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.
Merit Medical Systems has a net margin of 9.05% compared to DENTSPLY SIRONA's net margin of -10.59%. Merit Medical Systems' return on equity of 15.61% beat DENTSPLY SIRONA's return on equity.
99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 3.2% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Merit Medical Systems has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.
DENTSPLY SIRONA received 20 more outperform votes than Merit Medical Systems when rated by MarketBeat users. However, 70.35% of users gave Merit Medical Systems an outperform vote while only 60.97% of users gave DENTSPLY SIRONA an outperform vote.
Merit Medical Systems presently has a consensus target price of $109.33, suggesting a potential upside of 14.95%. DENTSPLY SIRONA has a consensus target price of $20.36, suggesting a potential upside of 28.48%. Given DENTSPLY SIRONA's higher probable upside, analysts plainly believe DENTSPLY SIRONA is more favorable than Merit Medical Systems.
In the previous week, Merit Medical Systems had 20 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 35 mentions for Merit Medical Systems and 15 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 1.10 beat Merit Medical Systems' score of 0.92 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.
Summary
Merit Medical Systems beats DENTSPLY SIRONA on 14 of the 19 factors compared between the two stocks.
Get DENTSPLY SIRONA News Delivered to You Automatically
Sign up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
DENTSPLY SIRONA Competitors List
Related Companies and Tools
This page (NASDAQ:XRAY) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy XRAY Stock Free XRAY Stock Alerts